- জেনেরিক নাম
- Abiraterone Acetate
- শক্তি
- 250 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Everest Pharmaceuticals Ltd.
- থেরাপিউটিক ক্লাস
- Cytotoxic Chemotherapy
৳ ৫৬৮.৪ ৳ ৫৮০.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
Abiraxen 250 mg Tablet একটি ট্যাবলেট ঔষধ, যার জেনেরিক নাম Abiraterone Acetate এবং শক্তি ২৫০ mg। তালিকাভুক্ত প্রতি ইউনিটের দাম ৫৮০.০০ টাকা। এটি তৈরি করে Everest Pharmaceuticals Ltd। ঔষধটি Cytotoxic Chemotherapy শ্রেণির অন্তর্ভুক্ত। Abiraterone Acetate-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Abiraterone Acetate-এর ৪টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ২টি। সবচেয়ে কম দাম Abiret 250 mg Tablet-এর, প্রতি ইউনিট ৳ ৫০০.০০।
Abiraxen is a tablet medicine manufactured by Everest Pharmaceuticals Ltd. Its active ingredient is abiraterone acetate, and each tablet has a strength of 250 mg. It belongs to a group of medicines called cytotoxic chemotherapy. It works by blocking an enzyme in the body that helps make androgens, which are hormones that can support prostate cancer growth. Doctors use it as part of treatment for certain stages of prostate cancer, always alongside other medicines and under specialist supervision. Treatment and monitoring are arranged by the treating doctor.
Abiraxen is used in adults with prostate cancer that has spread, in two situations: cancer that no longer responds to castration treatment, and high-risk cancer that still responds to castration. It is given together with prednisone and, where appropriate, another hormone treatment or after surgery to remove the testes. Only a specialist doctor can decide whether this medicine is suitable.
Swallow the tablet whole with water; do not crush or chew it. Take it on an empty stomach, at least one hour before or two hours after a meal. The doctor decides the dose, the timing and how long treatment continues, and may change the plan based on blood tests and your condition. Do not start, stop or change the medicine on your own. Ask your doctor or pharmacist if you are unsure how to take it.
Common side effects include tiredness, joint pain, high blood pressure, nausea, swelling, low potassium, hot flushes, diarrhoea, vomiting, upper respiratory infection, cough and headache. Some people may have more serious problems affecting the liver, blood pressure, potassium levels or hormone balance. Tell your doctor promptly about any new or worsening symptoms. Your doctor will arrange checks during treatment. Ask your doctor or pharmacist about anything you notice.
Before starting Abiraxen, tell your doctor about heart disease, high blood pressure, low potassium, liver problems or previous hormone-related illness, because monitoring and extra care may be needed. This medicine is not for women; it can harm a pregnancy and safety in females has not been established. It should not be used during breastfeeding. Do not use it if you are allergic to abiraterone acetate or any other ingredient. Tell your doctor about all other medicines you take, as some can interact. The doctor will decide on monitoring and any dose changes.
Abiraxen is a cytotoxic chemotherapy medicine containing abiraterone acetate. It is used in adults with certain stages of spread prostate cancer, together with prednisone and sometimes other hormone treatment. Only a specialist doctor can decide if it is right for you.
Swallow the tablet whole with water on an empty stomach, at least one hour before or two hours after food. Do not crush or chew it. The doctor decides the dose, timing and length of treatment, and may adjust the plan after checks. Never change the medicine yourself.
Abiraxen comes as a tablet, which is a solid oral dosage form you swallow. The strength of 250 mg means each tablet contains 250 mg of abiraterone acetate. The doctor decides how the medicine is used for your treatment.
The listed price is ৳ ৫৮০.০০. Your pharmacy can confirm availability and any dispensing charges. Ask your doctor or pharmacist if you need help understanding the cost of your treatment.
৳ ৫৬৮.৪ ৳ ৫৮০.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Abiraterone Acetate is converted in vivo to Abiraterone, an androgen biosynthesis inhibitor, that inhibits 17 α-hydroxylase/C17, 20-lyase (CYP17). This enzyme is expressed in testicular, adrenal, and prostatic tumor tissues and is required for androgen biosynthesis. CYP17 catalyzes two sequential reactions:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Drugs That Inhibit Or Induce CYP3A4 Enzymes: Based on in vitro data, Abiraxen is a substrate of CYP3A4. In a dedicated drug interaction trial, co-administration of Rifampin, a strong CYP3A4 inducer, decreased exposure of Abiraxen by 55%. Avoid concomitant strong CYP3A4 inducers during Abiraxen treatment. If a strong CYP3A4 inducer must be co-administered, increase the Abiraxen dosing frequency. In a dedicated drug interaction trial, co-administration of ketoconazole, a strong inhibitor of CYP3A4, had no clinically meaningful effect on the pharmacokinetics of Abiraxen.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypersensitivity to the Abiraterone acetate or to any of the excipients of Abiraterone.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The safety and efficacy of Abiraterone have not been established in females. Based on findings from animal studies and the mechanism of action, Abiraterone can cause fetal harm and potential loss of pregnancy. There are no human data on the use of Abiraterone in pregnant women. The safety and efficacy of Abiraterone have not been established in females. There is no information available on the presence of abiraterone acetate in human milk, or on the effects on the breastfed child or milk production.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Abiraxen may cause hypertension, hypokalemia, and fluid retention as a consequence of increased mineralocorticoid levels resulting from CYP17 inhibition. Patients should be monitored for hypertension, hypokalemia, and fluid retention at least once a month. Hypertension and hypokalemia should be controlled and corrected before and during treatment with Abiraxen. Patients should be monitored for symptoms and signs of adrenocortical insufficiency. Serum transaminases (ALT and AST) and bilirubin levels should be measured prior to starting treatment with Abiraxen, every two weeks for the first three months of treatment and monthly thereatier.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is no specific antidote. In the event of an overdose, Abiraxen should be stopped, general supportive measures are undertaken, including monitoring for arrhythmias and cardiac failure and assess liver function.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।